Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

AIMS: Individualization of cancer chemotherapy based on the patient’s genetic makeup holds promise for reducing side effects and improving efficacy. However, the relative contribution of genetics to drug response is unknown. MATERIALS & METHODS: In this study, we investigated the cytotoxic effec...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Peters, Eric J, Motsinger-Reif, Alison, Havener, Tammy M, Everitt, Lorraine, Hardison, Nicholas E, Watson, Venita G, Wagner, Michael, Richards, Kristy L, Province, Mike A, McLeod, Howard L
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3399590/
https://ncbi.nlm.nih.gov/pubmed/22008047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.11.92
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki